Business

The ratechnologies, the winner of the 2021 ADRIQ Innovation Awards in the “Life Sciences” category of the Canadian Business Journal

Montreal, November 26, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX) focuses on the development and commercialization of innovative treatments for biotechnology. It is a pharmaceutical company. Received the 2021 Innovation Award in the “Life Sciences” category at the 31st ADRIQ Innovation Awards Gala held on November 25, 2021.

Each year, the ADRIQ (Associationpourledéveloppement delarecherche et de l’innovation du Québec) Gala rewards Quebec-based companies for leadership in innovation in their respective fields.

At the beginning of 2021, Theratechnologies announced the US Food and Drug Administration’s TH1902 “Fast Track” as a single agent for the treatment of patients with advanced and recurrent solid tumors that express sortilin receptors and are refractory to standard treatment. I received the designation. TH1902 is a major peptide-drug complex derived from SORT1 + Technology ™ in oncology.

“It is very rare to get a“ fast track ”design early in the drug development process, which was achieved by extensive preclinical data. We are very proud of this achievement and look forward to the future with great hope for our patients, “said Paul Lévesque, President and Chief Executive Officer of Theratechnologies.

About TH1902
TH1902 combines Docetaxel with a peptide unique to Theratechnologies. This peptide-drug complex is a prime candidate for SORT1 + Technology ™ from Theratechnologies in oncology.

Through the consortium Québécois surladécouvertedumédicament (CQDM), the Canadian Cancer Society and the Government of Quebec have donated a total of $ 1.4 million to some of the research currently underway to develop the oncology platform covered by Theratechnologies.

About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on developing and commercializing innovative therapies to meet unmet medical needs. For more information on Theratechnologies, please visit our website (www.theratech.com), SEDAR (SEDAR). www.sedar.com And EDGAR’s www.sec.gov.

For media and investor inquiries:
Philip Dubuck
Senior Vice President and Chief Financial Officer
514 336-7800
Communications@theratech.com


CBJ News Maker

The ratechnologies, the winner of the 2021 ADRIQ Innovation Awards in the “Life Sciences” category of the Canadian Business Journal

Source link The ratechnologies, the winner of the 2021 ADRIQ Innovation Awards in the “Life Sciences” category of the Canadian Business Journal

Related Articles

Back to top button